FilingReader Intelligence
Zhejiang Medicine net profit surges 114% despite revenue decline
August 26, 2025 at 11:14 AM UTC•By FilingReader AI
Zhejiang Medicine reported net profit jumped 113.52% to RMB 673.3m in the first half of 2025, despite revenue falling 1.87% to RMB 4.32bn.
The company appointed Li Nanhang as executive director and legal representative, alongside new audit committee members.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Zhejiang Medicine publishes news
Free account required • Unsubscribe anytime